Enter your login e-mail to the account
Search
Search parameters
Search results
- The complications of lung cancer diagnostic process
MUDr. Radka Cahajlová, MUDr. Marián Marták
(6/2014, Original articles & case reports ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - Lung cancer in elderly
doc. MUDr. Mária Wagnerová, CSc.
(1/2007, Review articles ) - Optimal timing of chemotherapy and radiotherapy for stage III non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc., h. doc. MUDr. Elena Bolješíková, CSc.
(4/2007, Review articles ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Patient registries – a need for real data in the context of efficacy, safety and cost effectiveness
PharmDr. Dominik Tomek, MPH, RNDr. Mária Pšenková, Ing. Branislav Balvan
(2/2010, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Diagnosis and treatment of malignant mesothelioma
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2019, Main topic ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - Financial expenditures in the context of pharmacotherapy of oncological diseases
doc. PharmDr. Tomáš Tesař, PhD., MBA, PhDr. Ľubica Hlinková, MPH
(1/2014, Main topic ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - VI. Dni mladých onkológov vo Vyhniach
MUDr. Oľga Szegheőová
(5/2010, Events ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Malignant peritoneal mesothelioma
MUDr. Karel Kroupa, PhD.
(1/2015, Review articles ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - Current indications for pemetrexed in the treatment of non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2009, Review articles ) - Pemetrexed - antifolate cytostatic drug for treatment of malignant pleural mesothelioma and non-small cell lung cancer
doc. PharmDr. Juraj Sýkora, CSc.
(4/2009, Drugs & drug classes ) - Chemotherapy of lung cancer – what is new in 2009?
doc. MUDr. Peter Beržinec, CSc.
(1/2010, Review articles ) - Aktuálne z ASCO 2009
doc. MUDr. Peter Beržinec, CSc., prof. MUDr. Stanislav Špánik, CSc., MUDr. Marián Streško
(4/2009, Events ) - A new trend in targeted (biologic) therapy of non-small cell lung cancer in the 2009 – maintenance therapy
MUDr. Peter Kasan
(1/2010, Review articles ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Original articles ) - Systemic therapy of pancreatic cancer
MUDr. Tomáš Šálek, MUDr. Iveta Andrezálová Vochyanová
(3/2012, Main topic ) - Malignant epithelial thymic neoplasms
MUDr. Ján Rajec, PhD., RNDr. Ivan Varga, PhD.
(3/2012, Review articles ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Vinflunine in the metastatic urothelial carcinoma treatment after disease progression on gemcitabine with cisplatin – case-report
doc. MUDr. Jozef Mardiak, CSc., mim. prof., doc. MUDr. Michal Mego, PhD., MUDr. Štefánia Lišková, MUDr. Patrik Palacka, PhD., MPH, MBA, MUDr. Jana Obertová, PhD.
(5/2013, Original articles & case reports ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - 12 12TH TH WORLD CONFERENCE ON LUNG CANCER, WORLD CONFERENCE ON LUNG CANCER,
doc. MUDr. Peter Beržinec, CSc.
(5/2007, Events ) - ODPORÚČANIA SLOVENSKEJ ONKOLOGICKEJ SPOLOČNOSTI SLS PRE ANTIEMETICKÚ LIEČBU V ONKOLÓGII
Slovenská onkologická spoločnosť
(6/2008, Information & comments ) - Antiemetic therapy – what has brought the last decade?
MUDr. Jana Obertová
(6/2010, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Správa z XLIX. ročníka Bratislavských onkologických dní, 18. – 19. 10. 2012
MUDr. Barbora Slabá
(6/2012, Events ) - VI. Bardejovské onkologické dni
MUDr. Jozef Chovanec
(4/2010, Events ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - 17. svetová konferencia o karcinóme pľúc
Doc. MUDr. Peter Beržinec, CSc.
(1/2017, Events ) - ZaujÍmavosti zo zahraničnej tlače
doc. MUDr. Peter Beržinec, CSc.
(1/2006, Review articles ) - Chemotherapy of hormone refractory prostate cancer
MUDr. Marta Škultétyová, MUDr. Andrea Mocná
(5/2009, Review articles ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Conservative treatment of rare thoracic tumors – thymoma and carcinoid
MUDr. Mária Černá, CSc.
(6/2011, Review articles ) - Chemotherapy for malignant pleural mesothelioma
doc. MUDr. Peter Beržinec, CSc.
(6/2011, Review articles ) - Radiotherapy in treatment of rare thoracic tumors
MUDr. Elena Bolješíková, CSc.
(6/2011, Review articles ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - Cytoreductive surgery combined with intraoperative hyperthermic intrathoracalis chemotherapy (HITHOC) for Stage I of malignant pleural mesothelioma – first experience
MUDr. Karel Kroupa PhD., MUDr. Dalibor Piovarči , MUDr. Richard Hrubý PhD.
(6/2011, Review articles ) - 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(6/2011, Information & comments )
- Adverse effects and drug interactions of nonsteroidal anti-inflammatory drugs and their management as seen by a pharmacist
Martin Doseděl
(2-3/2014, Current pharmacotherapy )